60.63
price up icon3.48%   2.04
pre-market  プレマーケット:  61.50   0.87   +1.43%
loading
前日終値:
$58.59
開ける:
$58.71
24時間の取引高:
940.57K
Relative Volume:
1.08
時価総額:
$2.82B
収益:
$1.35B
当期純損益:
$163.34M
株価収益率:
18.51
EPS:
3.2763
ネットキャッシュフロー:
$189.17M
1週間 パフォーマンス:
+5.44%
1か月 パフォーマンス:
-15.99%
6か月 パフォーマンス:
+14.14%
1年 パフォーマンス:
-5.40%
1日の値動き範囲:
Value
$58.43
$60.78
1週間の範囲:
Value
$55.95
$60.78
52週間の値動き範囲:
Value
$47.31
$87.32

Haemonetics Corp Stock (HAE) Company Profile

Name
名前
Haemonetics Corp
Name
セクター
Healthcare (1110)
Name
電話
(781) 848-7100
Name
住所
125 SUMMER STREET, BOSTON, MA
Name
職員
3,023
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
HAE's Discussions on Twitter

Compare HAE vs ABT, SYK, MDT, BSX, EW

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
HAE
Haemonetics Corp
60.63 2.72B 1.35B 163.34M 189.17M 3.2763
Medical Devices icon
ABT
Abbott Laboratories
113.29 195.21B 44.33B 6.48B 6.92B 3.7033
Medical Devices icon
SYK
Stryker Corp
377.32 141.28B 25.12B 3.25B 4.28B 8.3984
Medical Devices icon
MDT
Medtronic Plc
98.49 123.60B 35.48B 4.64B 5.41B 3.5856
Medical Devices icon
BSX
Boston Scientific Corp
76.28 113.14B 20.08B 2.89B 3.82B 1.9391
Medical Devices icon
EW
Edwards Lifesciences Corp
78.98 45.52B 6.07B 1.06B 799.60M 1.8527

Haemonetics Corp Stock (HAE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-12-15 ダウングレード Needham Buy → Hold
2025-12-11 ダウングレード Citigroup Buy → Neutral
2025-08-11 ダウングレード Raymond James Strong Buy → Outperform
2025-08-08 繰り返されました Barrington Research Outperform
2025-08-08 ダウングレード JP Morgan Overweight → Neutral
2025-07-09 アップグレード Citigroup Neutral → Buy
2025-06-26 開始されました Robert W. Baird Outperform
2025-02-07 ダウングレード BofA Securities Neutral → Underperform
2024-12-06 開始されました JP Morgan Overweight
2024-11-08 アップグレード Raymond James Outperform → Strong Buy
2024-09-13 開始されました CL King Buy
2024-09-11 開始されました BofA Securities Neutral
2024-09-10 開始されました BTIG Research Buy
2024-06-12 アップグレード Needham Hold → Buy
2022-10-13 開始されました Mizuho Buy
2022-01-27 ダウングレード Needham Buy → Hold
2021-12-15 ダウングレード Citigroup Buy → Neutral
2021-08-17 再開されました Raymond James Outperform
2021-06-17 開始されました Citigroup Buy
2021-05-14 アップグレード CJS Securities Market Perform → Market Outperform
2021-04-20 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-04-19 ダウングレード CJS Securities Market Outperform → Market Perform
2021-02-03 アップグレード Barrington Research Mkt Perform → Outperform
2021-01-21 ダウングレード Barrington Research Outperform → Mkt Perform
2020-11-05 アップグレード Barrington Research Mkt Perform → Outperform
2020-05-06 ダウングレード Barrington Research Outperform → Mkt Perform
2020-03-31 アップグレード CJS Securities Market Perform → Market Outperform
2020-01-10 開始されました Needham Buy
2019-08-07 繰り返されました Barrington Research Outperform
2019-05-14 アップグレード Raymond James Mkt Perform → Outperform
2019-05-08 繰り返されました Barrington Research Outperform
2018-08-09 繰り返されました Barrington Research Outperform
2018-02-07 繰り返されました Barrington Research Outperform
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-11-08 繰り返されました Barrington Research Outperform
2017-08-08 アップグレード Barrington Research Mkt Perform → Outperform
2017-07-13 アップグレード JMP Securities Mkt Perform → Mkt Outperform
2017-02-07 ダウングレード Barrington Research Outperform → Mkt Perform
2016-11-08 アップグレード Barrington Research Mkt Perform → Outperform
2016-11-07 繰り返されました The Benchmark Company Hold
2016-09-20 ダウングレード CJS Securities Market Outperform → Market Perform
2016-08-15 ダウングレード Sidoti Buy → Neutral
2016-08-02 繰り返されました Jefferies Buy
2016-08-02 繰り返されました The Benchmark Company Hold
すべてを表示

Haemonetics Corp (HAE) 最新ニュース

pulisher
Feb 18, 2026

Haemonetics Corporation $HAE Stock Holdings Lessened by Heartland Advisors Inc. - MarketBeat

Feb 18, 2026
pulisher
Feb 18, 2026

ABN Amro Investment Solutions Buys Shares of 200,000 Haemonetics Corporation $HAE - MarketBeat

Feb 18, 2026
pulisher
Feb 18, 2026

Haemonetics Corporation (HAE) Q3 Performance Prompts Baird Model Update, Price Target Falls to $81 - Finviz

Feb 18, 2026
pulisher
Feb 17, 2026

Growth Recap: Will Haemonetics Corporation outperform its industry peersJuly 2025 EndofMonth & Long-Term Safe Return Strategies - baoquankhu1.vn

Feb 17, 2026
pulisher
Feb 17, 2026

Assessing Haemonetics (HAE) Valuation After Recent Share Price Weakness - Yahoo Finance

Feb 17, 2026
pulisher
Feb 17, 2026

A Look At Haemonetics (HAE) Valuation After Recent Share Price Weakness - simplywall.st

Feb 17, 2026
pulisher
Feb 16, 2026

Strong Competitive Position Drove Haemonetics Corporation’s (HAE) Earnings Growth - Yahoo Finance

Feb 16, 2026
pulisher
Feb 15, 2026

Short Interest in Haemonetics Corporation (NYSE:HAE) Decreases By 21.7% - MarketBeat

Feb 15, 2026
pulisher
Feb 14, 2026

Haemonetics Corporation $HAE Shares Sold by Principal Financial Group Inc. - MarketBeat

Feb 14, 2026
pulisher
Feb 13, 2026

Haemonetics Releases 2024-2025 Corporate Responsibility Report - The Globe and Mail

Feb 13, 2026
pulisher
Feb 13, 2026

Haemonetics (HAE) Balances Softer Interventional Sales With Buybacks – What Story Does Guidance Tell? - simplywall.st

Feb 13, 2026
pulisher
Feb 12, 2026

5 Revealing Analyst Questions From Haemonetics's Q4 Earnings Call - Finviz

Feb 12, 2026
pulisher
Feb 12, 2026

5 Revealing Analyst Questions From Haemonetics’s Q4 Earnings Call - Yahoo Finance

Feb 12, 2026
pulisher
Feb 11, 2026

Skylands Capital LLC Has $3.97 Million Stock Holdings in Haemonetics Corporation $HAE - MarketBeat

Feb 11, 2026
pulisher
Feb 10, 2026

Haemonetics (HAE) International Revenue Performance Explored - Yahoo Finance

Feb 10, 2026
pulisher
Feb 10, 2026

Key Players in the Autotransfusion Systems MarketHaemonetics - openPR.com

Feb 10, 2026
pulisher
Feb 09, 2026

Chuck Royce's Strategic Moves: Significant Reduction in Haemonetics Corp - Yahoo Finance

Feb 09, 2026
pulisher
Feb 09, 2026

Why Haemonetics (HAE) is a Top Value Stock for the Long-Term - Yahoo Finance

Feb 09, 2026
pulisher
Feb 08, 2026

A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $75 to $94 - 富途牛牛

Feb 08, 2026
pulisher
Feb 08, 2026

Haemonetics raises fiscal 2026 guidance as plasma and blood management drive 8%-10% organic growth outlook - MSN

Feb 08, 2026
pulisher
Feb 07, 2026

Haemonetics Earnings Call: Strong Core, IVT Drag - TipRanks

Feb 07, 2026
pulisher
Feb 07, 2026

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Haemonetics (HAE) and Denali Therapeutics (DNLI) - The Globe and Mail

Feb 07, 2026
pulisher
Feb 07, 2026

Why Haemonetics (HAE) Raised 2026 Guidance After Strong Plasma And Tech Results And What It Signals - Yahoo Finance

Feb 07, 2026
pulisher
Feb 07, 2026

Haemonetics (HAE) Margin Strength In Q3 2026 Reinforces Earnings Led Bullish Narratives - simplywall.st

Feb 07, 2026
pulisher
Feb 06, 2026

Haemonetics Q3 Earnings Call Highlights - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Haemonetics (NYSE:HAE) Trading Down 5.6%Here's What Happened - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Haemonetics stock slides 7% as revenue dip and hospital softness blunt raised outlook - TechStock²

Feb 06, 2026
pulisher
Feb 06, 2026

Citigroup Lowers Price Target for Haemonetics (HAE) to $75 | HAE Stock News - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Mizuho Lowers Haemonetics (HAE) Price Target, Maintains Outperfo - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Haemonetics (HAE) Rating Update: Barrington Research Raises Pric - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Haemonetics Q3 Earnings & Revenues Beat, Margins Up, Stock Slips - Yahoo Finance

Feb 06, 2026
pulisher
Feb 06, 2026

Haemonetics' (HAE) "Buy" Rating Reaffirmed at BTIG Research - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Haemonetics Corporation (NYSE:HAE) Q3 2026 Earnings Call Transcript - Insider Monkey

Feb 06, 2026
pulisher
Feb 06, 2026

Haemonetics price target raised to $94 from $93 at Barrington - TipRanks

Feb 06, 2026
pulisher
Feb 06, 2026

Haemonetics (HAE) Valuation Check After Q3 Beat And Higher 2026 Guidance - simplywall.st

Feb 06, 2026
pulisher
Feb 06, 2026

HAE Q4 Deep Dive: Plasma Momentum and Hospital Weakness Shape Mixed Results - Finviz

Feb 06, 2026
pulisher
Feb 06, 2026

Haemonetics Q3 2026 slides: Margin expansion and cash flow surge despite revenue transition By Investing.com - Investing.com South Africa

Feb 06, 2026
pulisher
Feb 06, 2026

Haemonetics stock maintains Market Outperform rating at Citizens on strong plasma growth - Investing.com Nigeria

Feb 06, 2026
pulisher
Feb 06, 2026

Haemonetics stock maintains Market Outperform rating at Citizens on strong plasma growth By Investing.com - Investing.com South Africa

Feb 06, 2026
pulisher
Feb 06, 2026

BTIG Reiterates Buy Rating and $88 Price Target on HAE | HAE Sto - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Baird lowers Haemonetics stock price target to $81 on mixed outlook By Investing.com - Investing.com South Africa

Feb 06, 2026
pulisher
Feb 06, 2026

Baird lowers Haemonetics stock price target to $81 on mixed outlook - Investing.com Nigeria

Feb 06, 2026
pulisher
Feb 06, 2026

Decoding Haemonetics Corp (HAE): A Strategic SWOT Insight - GuruFocus

Feb 06, 2026
pulisher
Feb 05, 2026

Haemonetics Q3 2026 slides: Margin expansion and cash flow surge despite revenue transition - Investing.com Canada

Feb 05, 2026
pulisher
Feb 05, 2026

Haemonetics (NYSE:HAE) Announces Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat

Feb 05, 2026
pulisher
Feb 05, 2026

Haemonetics Corp (HAE) Q3 2026 Earnings Call Highlights: Strong - GuruFocus

Feb 05, 2026
pulisher
Feb 05, 2026

Haemonetics reports Q3 adjusted EPS $1.31, consensus $1.25 - TipRanks

Feb 05, 2026
pulisher
Feb 05, 2026

Haemonetics HAE Q3 2026 Earnings Call Transcript - The Globe and Mail

Feb 05, 2026
pulisher
Feb 05, 2026

Haemonetics (HAE) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance

Feb 05, 2026
pulisher
Feb 05, 2026

Haemonetics (HAE) Exceeds Q3 Revenue Expectations with Strong Pe - GuruFocus

Feb 05, 2026
pulisher
Feb 05, 2026

Haemonetics's (NYSE:HAE) Q4 CY2025 Sales Top Estimates, Stock Soars - Finviz

Feb 05, 2026

Haemonetics Corp (HAE) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_devices ZBH
$98.25
price up icon 1.13%
medical_devices STE
$249.35
price up icon 1.61%
$72.80
price up icon 3.37%
medical_devices PHG
$31.48
price up icon 0.83%
$82.95
price up icon 1.64%
medical_devices EW
$78.98
price up icon 0.68%
大文字化:     |  ボリューム (24 時間):